ACELRX PHARMACEUTICALS INC 4
4 · ACELRX PHARMACEUTICALS INC · Filed Feb 18, 2016
Insider Transaction Report
Form 4
Mitchell Jane Wright
Chief Legal Officer
Transactions
- Award
Common Stock (Right to Buy)
2016-02-10+90,000→ 90,000 totalExercise: $3.40From: 2017-02-10Exp: 2026-02-09→ Common Stock (90,000 underlying)
Footnotes (3)
- [F1]Issued pursuant to the 2011 Equity Incentive Plan.
- [F2]The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (February 10, 2016) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months.
- [F3]The shares have double-trigger acceleration on a change of control.